Assessing Efficacy of a Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

Status: Recruiting
Location: See location...
Intervention Type: Other, Behavioral, Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This clinical trial evaluates light therapy and occupational therapy in improving cancer related fatigue (CRF) patients with genitourinary cancers. Light therapy is a non-pharmacological and evidence-based intervention for managing fatigue in cancer patients. The use of light therapy can provide a low burden, inexpensive, and easy to disseminate intervention approach that can potentially have a larger impact on CRF. In addition, occupational therapy is a standard, but often underutilized, component of the multi-disciplinary approach to cancer care. Using the combination of light therapy and occupational therapy may be effective in CRF management.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Aged 18 and over

• Sufficiently fluent in English

• On active treatment receiving systemic therapy (e.g., chemotherapy, immunotherapy, hormonal therapy, etc.) or radiotherapy

• Patients with diagnosis of a genitourinary (GU) cancer (e.g., prostate, kidney, and bladder cancer) who have grade 1 or 2 fatigue based on physician assessment at the time of study entry

• Clinician assessed prognosis of greater than or equal to six months

• Willing and independently able to provide consent

• Receive a pre-screen FACIT-Fatigue score of less than or equal to 30

Locations
United States
California
City of Hope Medical Center
RECRUITING
Duarte
Time Frame
Start Date: 2022-11-29
Estimated Completion Date: 2027-05-25
Participants
Target number of participants: 224
Treatments
Experimental: Arm I (BWL)
Patients self-administer 30 minutes of light delivered via light glasses every morning for 3 months. Patients attend 6 follow up sessions to address any questions regarding the wearable light therapy glasses.
Experimental: Arm II (OT)
Patients undergo 6 occupational therapist-led sessions over 60 minutes each.
Experimental: Arm III (OT, BWL)
Patients self-administer 30 minutes of light delivered via light glasses every morning for 3 months. Patients attend 6 follow up sessions to address any questions regarding the wearable light therapy glasses and to complete the occupational therapist-led session over 60 minutes.
Active_comparator: Arm IV (Control)
Patients undergo routine treatment and usual follow up care with their medical oncologist.
Related Therapeutic Areas
Sponsors
Leads: City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)

This content was sourced from clinicaltrials.gov